Literature DB >> 15913603

Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.

Maria G Sanchez1, Ana M Sanchez, Beatriz Collado, Sophie Malagarie-Cazenave, Nuria Olea, Maria J Carmena, Juan C Prieto, Ines Diaz-Laviada I.   

Abstract

Vanilloid receptor subtype-1 (TRPV1), the founding member of the vanilloid receptor-like transient receptor potential channel family, is a non-selective cation channel that responds to noxious stimuli such as low pH, painful heat and irritants. In the present study, we show, as means of reverse transcriptase-polymerase chain reaction and Western blot analysis, that the vanilloid TRPV1 receptor is expressed in the prostate epithelial cell lines PC-3 and LNCaP as well as in human prostate tissue. The kinetic parameters inferred from [(125)I]-resiniferatoxin binding were in concordance with data of TRPV1 receptors expressed in other tissues. The contribution of the endogenously expressed TRPV1 channel to intracellular calcium concentration increase in the prostate cells was studied by measuring changes in Fura-2 fluorescence by fluorescence microscopy. Addition of capsaicin, (R)-methanandamide and resiniferatoxin to prostate cells induced a dose-dependent increase in the intracellular calcium concentration that was reversed by the vanilloid TRPV1 receptor antagonist capsazepine. These results indicate that the vanilloid TRPV1 receptor is expressed and functionally active in human prostate cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913603     DOI: 10.1016/j.ejphar.2005.04.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  45 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

2.  Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Mariagrazia Iappelli; Roberta Verde; Colin G Stott; Luigia Cristino; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 3.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

Review 4.  Potential therapeutic value of transient receptor potential channels in male urogenital system.

Authors:  Gamze Toktanis; Ecem Kaya-Sezginer; Didem Yilmaz-Oral; Serap Gur
Journal:  Pflugers Arch       Date:  2018-09-07       Impact factor: 3.657

5.  Reactive intermediates produced from the metabolism of the vanilloid ring of capsaicinoids by p450 enzymes.

Authors:  Christopher A Reilly; Fred Henion; Tim S Bugni; Manivannan Ethirajan; Chris Stockmann; Kartick C Pramanik; Sanjay K Srivastava; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2012-11-06       Impact factor: 3.739

6.  G protein-coupled receptor signaling via Src kinase induces endogenous human transient receptor potential vanilloid type 6 (TRPV6) channel activation.

Authors:  Jennifer Spehr; Lian Gelis; Markus Osterloh; Sonja Oberland; Hanns Hatt; Marc Spehr; Eva M Neuhaus
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

Review 7.  Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?

Authors:  Arpad Szallasi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06-14       Impact factor: 3.000

Review 8.  The endocannabinoid system in prostate cancer.

Authors:  Inés Díaz-Laviada
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

9.  TRPV1 channel as a target for cancer therapy using CNT-based drug delivery systems.

Authors:  Andres Ortega-Guerrero; John M Espinosa-Duran; Jaime Velasco-Medina
Journal:  Eur Biophys J       Date:  2016-02-13       Impact factor: 1.733

10.  Vanilloids induce oral cancer apoptosis independent of TRPV1.

Authors:  Cara B Gonzales; Nameer B Kirma; Jorge J De La Chapa; Richard Chen; Michael A Henry; Songjiang Luo; Kenneth M Hargreaves
Journal:  Oral Oncol       Date:  2014-01-14       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.